πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6066642

Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their p

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6066656

2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonami

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6066657

Benzofuran-4-carboxamides and their therapeutic use

Darwin Discovery Limited Β· Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6066675

Method for treatment of retinal diseases

The Regents of the University of California Β· Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6066778

Transgenic mice expressing APC resistant factor V

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6066337

Method for producing a rapidly dissolving dosage form

The Board of Regents of the University of Oklahoma and Janssen Β· Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063371

Pharmaceutical compositions comprising a soluble interleukin-4 receptor

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063373

Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scaveng

Maxim Pharmaceuticals, Inc. Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063582

Methods of screening for compounds that interact with human P.sub.2u2 purinergic receptor

COR Therapeutics, Inc. Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063622

Adenovirus vectors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063794

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063905

Recombinant human IGA-J. chain dimer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063910

Preparation of protein microparticles by supercritical fluid precipitation

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6063138

Method and apparatus for the formation of particles

Bradford Particle Design Limited Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060270

Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro ki

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060238

Method and composition for regulating apoptosis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060582

Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-r

The Board of Regents of the University of Texas System Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060515

Treatment of skin conditions by use of PPAR.alpha. activators

The Regents of the University of California Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060505

Method of treating cancer using C-26 modified bryostatin

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060500

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

The Board of Regents of the University of Texas System Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060458

Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060311

Retinoid suppression of ventricular muscle cell hypertrophy

The Regents of the University of California Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060310

Transcription factor decoy and tumor growth inhibitor

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6060276

Nucleic acids encoding novel orphan cytokine receptors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired